Cytokinetics (CYTK) Non Operating Interest Expenses (2012 - 2025)
Cytokinetics' Non Operating Interest Expenses came in at $14.27 million for Q4 2025, up 59.7% from $8.94 million a year earlier and up 25.7% from the prior quarter.
Powered by 
Analysis
Cytokinetics (CYTK) Non Operating Interest Expenses (2012 - 2025) Analysis & Trends
For FY2025, Cytokinetics' Non Operating Interest Expenses was $45.58 million, up 20.9% from FY2024.
- Non Operating Interest Expenses has increased in each of the last ten years, with a five-year compound annual growth rate of 23.3% (FY2020 to FY2025).
- Going back by year, Non Operating Interest Expenses was $37.7 million in FY2024 (+33.2%), $28.31 million in FY2023 (+45.8%), $19.41 million in FY2022 (+18.1%) and $16.44 million in FY2021 (+3.0%).
- The Q4 2025 figure represents the highest quarterly Non Operating Interest Expenses in data going back to Q3 2012.
- Year-over-year, Non Operating Interest Expenses increased in six of the last seven quarters, with growth averaging 29.5%.
- The fastest year-over-year change in Non Operating Interest Expenses over five years came in Q1 2023 (growth of 153.5%), and the weakest in Q1 2022 (a decline of 31.1%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 217.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -477.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 653.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 269.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Cytokinetics | 7.83 Bn | 3.24 Bn | 47.10 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 14.27 Mn |
| Sep 30, 2025 | 11.35 Mn |
| Jun 30, 2025 | 11.08 Mn |
| Dec 31, 2024 | 8.94 Mn |
| Sep 30, 2024 | 8.93 Mn |
| Jun 30, 2024 | 12.73 Mn |
| Mar 31, 2024 | 7.10 Mn |
| Dec 31, 2023 | 7.16 Mn |
| Sep 30, 2023 | 7.14 Mn |
| Jun 30, 2023 | 7.05 Mn |
| Mar 31, 2023 | 6.96 Mn |
| Dec 31, 2022 | 7.06 Mn |
| Sep 30, 2022 | 6.80 Mn |
| Jun 30, 2022 | 2.81 Mn |
| Mar 31, 2022 | 2.75 Mn |
| Dec 31, 2021 | 4.22 Mn |
| Sep 30, 2021 | 4.16 Mn |
| Jun 30, 2021 | 4.07 Mn |
| Mar 31, 2021 | 3.99 Mn |
| Dec 31, 2020 | 4.02 Mn |
API Access
Cytokinetics Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=CYTK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "CYTK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=CYTK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();